Research Article

Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma

Table 1

Clinical characteristics of participants.

VariablePatient (N = 184)Control (N = 196) value

Age (years, mean±SD)56.3 ± 16.455.5 ± 16.60.947

Age group (years), N (%)
 ≤6082 (44.6)87 (44.4)0.972
 > 60102 (55.4)109 (55.6)

Gender, N (%)
 Male125 (67.9)134 (68.4)0.928
 Female59 (32.1)62 (31.6)

Smoking habit, N (%)
 Yes102 (55.4)93 (47.4)0.12
 No82 (44.6)103 (52.6)

Drinking habit, N (%)
 Yes134 (72.8)149 (76)0.475
 No50 (27.2)47 (24)

Tumor site, N (%)
 Tongue83 (45.1)
 Nontongue101 (54.9)

T-stage, N (%)
 T1 + T2111 (60.3)
 T3 + T473 (39.7)

N-stage, N (%)
 Positive69 (37.5)
 Negative115 (62.5)

TNM stage, N (%)
 I-II104 (56.5)
 III-IV80 (43.5)

Histologic grade, N (%)
 Well + moderate120 (65.2)
 Poor64 (34.8)

Mean value<0.05.